Guggenheim Capital LLC Heron Therapeutics, Inc. Transaction History

Guggenheim Capital LLC

$14 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$2.25 - $4.67 $11,835 - $24,564	-5,260 Reduced 16.24%	27,123 $67,000
Q3 2022 Nov 14, 2022	SELL	$2.66 - $5.37 $76,041 - $153,512	-28,587 Reduced 46.89%	32,383 $137,000
Q2 2022 Aug 15, 2022	SELL	$2.3 - $6.29 $11,311 - $30,934	-4,918 Reduced 7.46%	60,970 $170,000
Q1 2022 May 16, 2022	BUY	$4.63 - $9.94 $3,069 - $6,590	663 Added 1.02%	65,888 $376,000
Q4 2021 Feb 14, 2022	BUY	$8.35 - $12.6 $3,782 - $5,707	453 Added 0.7%	65,225 $596,000
Q3 2021 Nov 15, 2021	SELL	$10.13 - $15.0 $1,843 - $2,730	-182 Reduced 0.28%	64,772 $692,000
Q2 2021 Aug 13, 2021	BUY	$13.27 - $18.48 $86,772 - $120,840	6,539 Added 11.19%	64,954 $1.01 Million
Q1 2021 May 13, 2021	BUY	$14.49 - $20.72 $357,569 - $511,307	24,677 Added 73.14%	58,415 $947,000
Q4 2020 Feb 16, 2021	BUY	$14.61 - $22.14 $177,862 - $269,532	12,174 Added 56.46%	33,738 $714,000
Q3 2020 Nov 13, 2020	BUY	$13.67 - $17.77 $294,779 - $383,192	21,564 New	21,564 $320,000
Q4 2019 Feb 14, 2020	SELL	$17.42 - $26.61 $1.65 Million - $2.53 Million	-94,895 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$16.36 - $21.39 $238,136 - $311,352	-14,556 Reduced 13.3%	94,895 $1.76 Million
Q2 2019 Aug 14, 2019	SELL	$16.93 - $26.22 $62,048 - $96,096	-3,665 Reduced 3.24%	109,451 $2.03 Million
Q1 2019 May 15, 2019	BUY	$23.15 - $28.34 $271,364 - $332,201	11,722 Added 11.56%	113,116 $2.76 Million
Q4 2018 Feb 14, 2019	BUY	$22.03 - $32.01 $2.09 Million - $3.04 Million	95,058 Added 1500.28%	101,394 $2.63 Million
Q3 2018 Nov 14, 2018	BUY	$30.0 - $40.85 $190,080 - $258,825	6,336 New	6,336 $201,000
Q4 2017 Feb 14, 2018	SELL	$14.8 - $18.85 $2.13 Million - $2.71 Million	-143,840 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$14.65 - $16.85 $2.11 Million - $2.42 Million	143,840	143,840 $2.32 Million

Others Institutions Holding HRTX

# of Institutions

180

Shares Held

121M

Call Options Held

80.4K

Put Options Held

94.9K

Rubric Capital Management LP New York, NY

26.7M
Shares

$28.6 Million
1.48% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

8.85M
Shares

$9.47 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

8.72M
Shares

$9.33 Million
0.0% of portfolio
Black Rock Inc. New York, NY

8.33M
Shares

$8.91 Million
0.0% of portfolio
Velan Capital Investment Management LP Alpharetta, GA

6.99M
Shares

$7.48 Million
28.8% of portfolio

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $127M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account